Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?

Affiliations

Comment

Kadri Altundag. Autoimmun Rev. 2022 Nov.

. 2022 Nov;21(11):103181.

doi: 10.1016/j.autrev.2022.103181. Epub 2022 Aug 18.

¹ MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey. Electronic address: altundag66@yahoo.com.

No abstract available

Keywords: Breast cancer; Risk factors; SSc.

Conflict of interest statement

Declaration of Competing Interest I have no conflict of interest.

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).
Carbonell C, Marcos M, Guillén-Del-Castillo A, Rubio-Rivas M, Argibay A, Marín-Ballvé A, Rodríguez-Pintó I, Baldà-Masmiquel M, Callejas-Moraga E, Colunga D, Sáez-Comet L, González-Echávarri C, Ortego-Centeno N, Marí-Alfonso B, Vargas-Hitos JA, Todolí-Parra JA, Trapiella L, Herranz-Marín MT, Freire M, Castro-Salomó A, Perales-Fraile I, Madroñero-Vuelta AB, Sánchez-García ME, Ruiz-Muñoz M, González-García A, Sánchez-Redondo J, de-la-Red-Bellvis G, Fernández-Luque A, Muela-Molinero A, Lledó GM, Tolosa-Vilella C, Fonollosa-Pla V, Chamorro AJ, Simeón-Aznar CP; RESCLE Investigators, Autoimmune Diseases Study Group (GEAS). Carbonell C, et al. Autoimmun Rev. 2022 Oct;21(10):103167. doi: 10.1016/j.autrev.2022.103167. Epub 2022 Aug 2. Autoimmun Rev. 2022. PMID: 35931315 Review.